Nicotine pouches get FDA approval

FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.
Zyn nicotine pouches get FDA approval
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.
FDA approves marketing of nicotine pouches
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches—small synthetic fiber pouches containing nicotine—are designed to be placed between a person's gum and lip.
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
FDA 'Closely Monitoring' Zyn Nicotine Pouches After Marketing Approval
Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time regulators have authorized sales of nicotine pouches.
For first time, FDA approves marketing of nicotine pouch products
The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an extensive scientific review of them.
FDA Allows Flavored Zyn Nicotine Pouches to Stay on the Market
The agency found Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.
FDA approves sale of Zyn nicotine pouches following extensive review
The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products. It is the first time the agency has authorized the sale of nicotine pouches,
WHYY1d
FDA regulation of nicotine pouches can help prevent youth use, say Rutgers researchers
Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized ...
US FDA officially authorises Zyn nicotine pouches for sale
The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be ...
News Medical on MSN4d
Nicotine pouch use among soldiers significantly higher than civilians
American soldiers are 10 times more likely to use nicotine pouches that can cause serious health issues than average American ...
Biden administration moves to limit nicotine in cigarettes and certain other tobacco products
The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of ...
Zyn Competitor Is Delivering on 'Unexpected' Ask of California Firefighters
Lucy, a competitor of the popular nicotine pouch Zyn, is delivering on an "unexpected" ask from firefighters battling the ...
MedPage Today4d
FDA Finally Proposes a Nicotine Crackdown, Years in the Making
On Wednesday, the FDA issued its long-awaited proposal to drastically limit the amount of nicotine in cigarettes and some ...